麻豆传媒

Christy Wyskiel is the Senior Advisor to the President of Johns Hopkins University for Innovation & Entrepreneurship. In this role, she also serves as the Executive Director of Johns Hopkins Technology Ventures, the division of the university responsible for technology transfer, industry research partnerships, and company incubation under the brand ‘FastForward.’ Since her appointment in 2013, Christy has transformed the culture of commercialization at Johns Hopkins, opening 43,000 square feet of FastForward innovation space to support startup companies, facilitating the creation of 160 companies, and generating $404 million in university revenue from licensing and industry collaborations. Johns Hopkins University startups have raised more than $3 billion in venture capital during her tenure. Christy is a fierce advocate for the future of Baltimore and the role that Johns Hopkins University can play in populating the city skyline with companies borne, built and grown locally. Christy is a seasoned entrepreneur, investor, and ecosystem builder with 25 years of experience primarily focused on the life sciences and healthcare industries. Prior to her role at Johns Hopkins, Christy co-founded two Baltimore based startups and served as a formal and informal advisor to many others. Prior to that, Christy worked as an institutional investor where she had a long track record of successful investing in both public and private companies. Christy has a BA in Economics and German from Williams College and an MBA in Accounting and Finance from the Stern School of Business at New York University.

Jay Schnitzer is senior vice president, chief technology officer, and chief medical officer at The MITRE Corporation. In this role, he directs the organization鈥檚 independent research and development (R&D) program and manages development of corporate technology strategy, which spans MITRE鈥檚 operating centers and sponsor community. He also leads corporate and national initiatives in health and life sciences, building coalitions leveraging the best talent across the nation in these communities.

Previously, as the director of biomedical sciences at MITRE, Schnitzer oversaw the organization鈥檚 health transformation R&D program. In that capacity, he identified opportunities for MITRE to make important, transformative, and impactful differences in healthcare for our sponsors and the nation. As part of this work, he led the writing and editing of the Integrated Report for the Independent Assessment performed in response to Section 201 of the Veterans Choice Act and organized and facilitated the Blue-Ribbon Panel. To support the Department of Veterans Affairs鈥� (VA) decision on its electronic health record (EHR) system, he facilitated a special Listening Forum for the VA Secretary in August 2017, at which industry experts on EHR implementation discussed leading practices. In January 2018, he organized a panel of EHR interoperability experts, which produced a report containing recommendations as input for the VA鈥檚 contract with a commercial EHR vendor.

Before joining MITRE, Schnitzer was the director of the Defense Sciences Office at DARPA, where he led a team of 20 program managers and 70 support staff overseeing R&D across multiple domains. In addition to life sciences, biomedical research, and quantum physics, these R&D areas included materials science, advanced mathematics, and engineering. 

Formerly, Schnitzer was chief medical officer and senior vice president at Boston Scientific Corporation (BSC). His responsibilities at BSC included medical and clinical oversight of the entire product lifecycle for all medical devices manufactured by four business divisions of the company: endoscopy, urology/women鈥檚 health, neurovascular, and neuromodulation.

Prior to BSC, Schnitzer was on staff at Massachusetts General Hospital as an attending pediatric surgeon, with a joint appointment at the Shriners Hospital for Children burn center and a faculty position at Harvard Medical School.

In recognition of his work on the COVID-19 Healthcare Coalition and his leadership of the MITRE independent R&D program, WashingtonExec named Schnitzer its 2020 Healthcare Industry Executive of the Year. The award recognizes executives fostering innovation for the federal government.

Schnitzer received a B.S. degree in chemical engineering from Worcester Polytechnic Institute, a Ph.D. in chemical engineering from MIT, and an M.D. from Harvard Medical School. He is board certified and re-certified in surgery and pediatric surgery.